リアルタ・インベストメント・アドバイザーは,iSharesバイオテクノロジーETFの株を90.4%削減し,他の投資家は,その株を増加させた. Realta Investment Advisors cut its stake in the iShares Biotechnology ETF by 90.4%, while other investors increased theirs.

Realta Investment Advisorsは4四半期にiShares Biotechnology ETF (IBB) の株式を90.4%大幅に削減し,BNP Paribas Financial MarketsやAppleton Partners Inc.などの他の投資家は株式を増やした. Realta Investment Advisors significantly reduced its shares in the iShares Biotechnology ETF (IBB) by 90.4% in the fourth quarter, while other investors like BNP Paribas Financial Markets and Appleton Partners Inc. increased their stakes. Hedgeファンドと施設投資家は,現在IBBの株式の6.25%を保有している. Hedge funds and institutional investors now own 62.45% of IBB's stock. ETFはNASDAQバイオバイオバイオテクノロジーのインデックスをたどって,最近0.0624ドルの配当をした. The ETF tracks the NASDAQ Biotechnology Index and recently paid a dividend of $0.0624.